Advertisement

UBS Turns Bullish on Nykaa: Here’s Why the Beauty Giant Stands Strong


Updated: March 07, 2025 12:21

Image Source: MoneyControl

Stay Ahead – Explore Now! AstraZeneca’s Big Win: Osimertinib Approval Ushers in New Era for Indian Cancer Patients

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement